| Pazopanib: A multikinase inhibitor with activity in advanced renal cell ... - UroToday |
|
|
UroTodayTreatment options for patients with metastatic renal cell carcinoma (RCC) have changed dramatically, and a new paradigm has evolved. ... read more |